Cantor Fitzgerald Predicts Centene FY2025 Earnings

Centene Co. (NYSE:CNC) – Equities researchers at Cantor Fitzgerald issued their FY2025 earnings per share (EPS) estimates for shares of Centene in a report issued on Tuesday, January 21st. Cantor Fitzgerald analyst S. James anticipates that the company will post earnings of $7.27 per share for the year. Cantor Fitzgerald has a “Overweight” rating and a $90.00 price objective on the stock. The consensus estimate for Centene’s current full-year earnings is $6.81 per share.

Several other research firms also recently issued reports on CNC. Barclays boosted their price objective on shares of Centene from $91.00 to $93.00 and gave the stock an “overweight” rating in a report on Friday, December 13th. Sanford C. Bernstein cut their price target on Centene from $96.00 to $88.00 and set an “outperform” rating for the company in a report on Wednesday, October 30th. Jefferies Financial Group cut Centene from a “hold” rating to an “underperform” rating and lowered their price objective for the company from $68.00 to $52.00 in a research report on Tuesday, December 10th. JPMorgan Chase & Co. reaffirmed an “overweight” rating and issued a $75.00 target price (down from $80.00) on shares of Centene in a research report on Tuesday, December 17th. Finally, Truist Financial lowered their price target on shares of Centene from $89.00 to $84.00 and set a “buy” rating on the stock in a report on Friday, December 13th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and ten have given a buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $80.92.

Centene Trading Up 2.3 %

Shares of CNC stock opened at $63.68 on Wednesday. The company has a current ratio of 1.10, a quick ratio of 1.10 and a debt-to-equity ratio of 0.64. Centene has a 1 year low of $55.03 and a 1 year high of $81.42. The firm’s fifty day simple moving average is $60.15 and its 200 day simple moving average is $67.30. The firm has a market capitalization of $32.15 billion, a P/E ratio of 11.06, a price-to-earnings-growth ratio of 0.83 and a beta of 0.45.

Insider Transactions at Centene

In related news, CFO Andrew Lynn Asher bought 17,200 shares of Centene stock in a transaction dated Wednesday, November 13th. The shares were bought at an average cost of $58.14 per share, for a total transaction of $1,000,008.00. Following the completion of the transaction, the chief financial officer now owns 486,847 shares of the company’s stock, valued at approximately $28,305,284.58. This trade represents a 3.66 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CEO Sarah London acquired 4,117 shares of the company’s stock in a transaction that occurred on Friday, November 8th. The stock was bought at an average price of $60.80 per share, with a total value of $250,313.60. Following the transaction, the chief executive officer now directly owns 667,229 shares in the company, valued at $40,567,523.20. The trade was a 0.62 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have acquired 45,010 shares of company stock valued at $2,660,276 in the last three months. 0.29% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the business. Harris Associates L P raised its stake in shares of Centene by 5.7% during the third quarter. Harris Associates L P now owns 26,314,183 shares of the company’s stock worth $1,980,932,000 after buying an additional 1,420,825 shares during the last quarter. State Street Corp lifted its stake in shares of Centene by 0.5% in the 3rd quarter. State Street Corp now owns 23,468,159 shares of the company’s stock valued at $1,766,683,000 after purchasing an additional 111,654 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in shares of Centene by 3.5% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 5,768,534 shares of the company’s stock worth $434,255,000 after purchasing an additional 194,566 shares during the last quarter. Legal & General Group Plc increased its holdings in Centene by 14.2% in the second quarter. Legal & General Group Plc now owns 5,113,759 shares of the company’s stock valued at $339,042,000 after purchasing an additional 636,683 shares during the last quarter. Finally, AQR Capital Management LLC lifted its stake in Centene by 22.9% in the second quarter. AQR Capital Management LLC now owns 4,461,517 shares of the company’s stock valued at $295,799,000 after buying an additional 832,318 shares during the period. 93.63% of the stock is currently owned by institutional investors and hedge funds.

About Centene

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.